Senior Director, Licensing Officer - Oncology

About the role

At Bayer, we believe work should matter. Every day, our teams push toward a future where "Health for all, Hunger for none" is within reach, and every role, from the lab to the field to the boardroom, helps us get there. We give people the ownership to shape outcomes, the support to grow through new skills and experiences, and a global community where different perspectives are valued. If you want your work to count and the room to become your best, you'll find it here.

The Senior Director, Scientific Licensing Officer identifies and advances high-value licensing, acquisition, and strategic collaboration opportunities that support Bayer Pharmaceuticals' Oncology strategy. This role requires deep scientific expertise and Oncology landscape knowledge, strong commercial acumen and business judgment, and exceptional partnering skills. Serving as Bayer's primary external representative to potential partners, the Senior Director evaluates opportunities, presents recommendations to senior leadership and governance committees, and may lead or support relevant transactions.

Responsibilities

• Lead technical, clinical, and commercial assessment of Oncology licensing and acquisition opportunities, applying deep scientific and landscape expertise to validate potential and synthesize findings for decision-making.
• Establish and maintain screening processes, coordinating multifunctional input and aligning screening strategy with Oncology stakeholders.
• Lead due diligence teams to identify, summarize, and mitigate project risks.
• Present assessments and recommendations to leadership and governance committees to secure approval through term sheet, diligence, and contracting stages, managing stakeholders to build alignment and support.
• Potentially participate in or lead (or co-lead) transactions including business case development, valuation, term sheet and contract negotiation, due diligence and transition to alliance management.
• Serve as Bayer's primary point of contact for potential partners, including representation at partnering and oncology conferences.
• Build and expand external networks across biotech, pharma, investors, and ecosystem partners to proactively source and evaluate opportunities.
• Shape and